EMA Medicines - Full Catalogue

Download Excel Data on EU Medicine Authorisations

EMA offers downloadable Excel data tables with detailed information on centrally authorised medicines, covering approved medicines, withdrawn marketing authorisation applications, post-authorisation procedure opinions, referrals, paediatric investigation plans, orphan designations, periodic safety update report single assessments (PSUSAs), direct healthcare professional communications (DHPCs), medicine supply shortages, herbal medicines, and medicines for use outside the EU. The website automatically updates these data tables overnight. Data includes information on medicines for which the European Commission has refused, suspended, or withdrawn a marketing authorisation.

EMA Monthly Medicines Under Evaluation Lists

The European Medicines Agency (EMA) publishes monthly updated lists of medicines for human use currently under evaluation by the Committee for Medicinal Products for Human Use (CHMP) for marketing authorisation in the EU via the centralised procedure. The April 2026 list of applications for new human medicines is available as an Excel file (EMA/80934/2026, 104.78 KB), first published on 14 April 2026, alongside extension applications and Type II variation procedure lists from February-March 2026.